Proinflammatory role of inducible nitric oxide synthase in acute hyperoxic lung injury

Respir Res. 2004 Sep 15;5(1):11. doi: 10.1186/1465-9921-5-11.

Abstract

Background: Hyperoxic exposures are often found in clinical settings of respiratory insufficient patients, although oxygen therapy (>50% O2) can result in the development of acute hyperoxic lung injury within a few days. Upon hyperoxic exposure, the inducible nitric oxide synthase (iNOS) is activated by a variety of proinflammatory cytokines both in vitro and in vivo. In the present study, we used a murine hyperoxic model to evaluate the effects of iNOS deficiency on the inflammatory response.

Methods: Wild-type and iNOS-deficient mice were exposed to normoxia, 60% O2 or >95% O2 for 72 h.

Results: Exposure to >95% O2 resulted in an increased iNOS mRNA and protein expression in the lungs from wild-type mice. No significant effects of iNOS deficiency on cell differential in bronchoalveolar lavage fluid were observed. However, hyperoxia induced a significant increase in total cell count, protein concentration, LDH activity, lipid peroxidation, and TNF-alpha concentration in the bronchoalveolar lavage fluid compared to iNOS knockout mice. Moreover, binding activity of NF-kappaB and AP-1 appeared to be higher in wild-type than in iNOS-deficient mice.

Conclusion: Taken together, our results provide evidence to suggest that iNOS plays a proinflammatory role in acute hyperoxic lung injury.

Publication types

  • Comparative Study

MeSH terms

  • Acute Disease
  • Animals
  • Bronchoalveolar Lavage Fluid / immunology
  • Cytokines / immunology
  • Hyperoxia / enzymology*
  • Immunologic Factors / immunology
  • Lung / enzymology*
  • Lung / immunology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NF-kappa B / immunology*
  • Nitric Oxide Synthase Type II / deficiency*
  • Nitric Oxide Synthase Type II / immunology*
  • Transcription Factor AP-1 / immunology*
  • Tumor Necrosis Factor-alpha

Substances

  • Cytokines
  • Immunologic Factors
  • NF-kappa B
  • Transcription Factor AP-1
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide Synthase Type II